Maravai LifeSciences Holdings, Inc. (MRVI) Investor Relations Documents

Maravai LifeSciences Holdings, Inc. (MRVI) investor relations documents from the company's IR site: 9 presentations, 20 press releases; latest deck 2026-08-07. Read in-app with summaries. First-party data.

Investor Presentation - August 2026: Maravai LifeSciences' August 2026 investor presentation highlights stabilization post-restructuring, with 1H'26 revenue up 24% to $117.3M and positive Adjusted EBITDA.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-07PresentationInvestor Presentation - August 2026
2026-08-06Press releaseMaravai LifeSciences Reports Second Quarter 2026 Financial Results
2026-08-06Earnings deckPresentation
2026-08-06Financial supplementGAAP/Non-GAAP reconciliation
2026-07-22Press releaseMaravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
2026-07-20Press releaseTriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping
2026-06-16Press releaseTriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
2026-06-03Press releaseMaravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
2026-05-18Press releaseMaravai LifeSciences To Attend The Jefferies Global Healthcare Conference
2026-05-08PresentationInvestor Presentation - May 2026
2026-05-07Press releaseMaravai LifeSciences Reports First Quarter 2026 Financial Results
2026-05-07Press releasePDF
2026-05-07Earnings deckPresentation
2026-05-07Financial supplementGAAP/Non-GAAP reconciliation
2026-04-20Press releaseMaravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026
2026-02-25Earnings deckPresentation
2026-02-25Financial supplementGAAP/Non-GAAP reconciliation
2026-02-09Press releaseMaravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
2025-11-10Press releaseMaravai LifeSciences Announces November 2025 Investor Conference Schedule
2025-11-06Financial supplementGAAP/Non-GAAP reconciliation
2025-11-06PresentationQ3 2025 Earnings
Press releaseMaravai LifeSciences Reports Second Quarter 2025 Financial Results
2025-08-11Financial supplementGAAP/Non-GAAP reconciliation
2025-08-11PresentationQ2 2025 Earnings
Press releaseMaravai Lifesciences Reports First Quarter 2025 Financial Results
2025-05-12Financial supplementGAAP/Non-GAAP reconciliation
2025-05-12PresentationQ1 2025 Earnings
2025-03-20PresentationPresentation
2025-03-19Financial supplementGAAP/Non-GAAP reconciliation
2025-03-18Press releaseMaravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results
2025-02-25Press releaseMaravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
2025-01-08Press releaseMaravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
2024-12-05Press releaseMaravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors
2024-11-12Press releaseMaravai LifeSciences Announces November 2024 Investor Conference Schedule
2024-11-07Press releaseMaravai LifeSciences Reports Third Quarter 2024 Financial Results
2024-10-15Press releaseMaravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024
2024-08-20Financial supplementGAAP/Non-GAAP reconciliation
2024-08-20Financial supplementGAAP/Non-GAAP reconciliation
2024-08-20Financial supplementGAAP/Non-GAAP reconciliation
2024-08-07Financial supplementGAAP/Non-GAAP reconciliation

MRVI overview · MRVI earnings · MRVI financials · MRVI KPIs · MRVI documents · MRVI ownership · MRVI peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.